SKI Market

A+| A| A-|

Indian Indices

Sensex

78,516.49 -756.84
( -0.95%)

Global Indices

Nasdaq

49,166.17 -297.40
(-0.60%)

Dow Jones

7,084.21 -45.93
(-0.64%)

Hang Seng

59,542.04 192.87
(0.32%)

Nikkei 225

10,480.54 -17.55
(-0.17%)

Forex

USD-INR

92.99 0.41
(0.45%)

EUR-INR

109.45 0.58
(0.53%)

GBP-INR

125.69 0.62
(0.49%)

JPY-INR

0.59 0.00
(0.33%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Influx Healthtech Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

93847

INE0MYZ01012

36.3489357

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INFLUX

46.16

616.61

EPS(TTM)

Face Value()

Div & Yield %

5.77

Back

Ridhi Synthetics standalone net profit declines 16.22% in the September 2025 quarter

Nov 15,2025

Net profit of Ridhi Synthetics declined 16.22% to Rs 0.31 crore in the quarter ended September 2025 as against Rs 0.37 crore during the previous quarter ended September 2024. Sales rose 9.09% to Rs 0.12 crore in the quarter ended September 2025 as against Rs 0.11 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.12	0.11	9
OPM %	-33.33	-27.27	-
PBDT	0.43	0.50	-14
PBT	0.41	0.49	-16
NP	0.31	0.37	-16

78,516.49 -756.84 ( -0.95%)

49,166.17 -297.40 (-0.60%)

7,084.21 -45.93 (-0.64%)

59,542.04 192.87 (0.32%)

10,480.54 -17.55 (-0.17%)

92.99 0.41 (0.45%)

109.45 0.58 (0.53%)

125.69 0.62 (0.49%)

0.59 0.00 (0.33%)